Help Pharmacy Prescription Process: How It Works, What It Costs, and Whether It's Worth It

At a glance
- Facility type / FDA-registered 503B outsourcing facility under Section 503B of the FD&C Act
- Location / Houston, Texas (primary campus exceeds 200,000 sq ft)
- Prescription required / Yes, from a licensed prescriber in your state
- Common categories / Compounded GLP-1 agonists, testosterone, thyroid, peptides, sexual health
- Typical turnaround / 3 to 5 business days after Rx receipt
- Shipping / Cold-chain overnight or 2-day, depending on medication stability requirements
- FDA compliance / Must follow current Good Manufacturing Practices (cGMP) per DQSA 2013
- Insurance / Most compounded medications are cash-pay; some FSA/HSA eligible
- Telehealth partners / Works with multiple telehealth platforms that handle the clinical intake
What Help Pharmacy Actually Is
Help Pharmacy operates as a 503B outsourcing facility under the Drug Quality and Security Act (DQSA) of 2013, which means it compounds medications in bulk without requiring patient-specific prescriptions before production begins [1]. This is different from a traditional 503A pharmacy, which compounds only after receiving an individual Rx.
503B vs. 503A: Why It Matters
The distinction carries real regulatory weight. A 503B facility must register with the FDA, submit to regular inspections, follow cGMP standards, and report adverse events [1]. A 503A pharmacy operates under state board oversight and is exempt from most FDA manufacturing requirements. Help's 503B status means its production environment is closer to a pharmaceutical manufacturer than a corner drugstore.
Scale and Scope
Based in Houston, Texas, Help's campus spans over 200,000 square feet. The facility compounds sterile injectables, oral capsules, topical creams, sublingual troches, and nasal sprays across therapeutic categories including endocrinology, sexual health, dermatology, and weight management. The pharmacy has been operational since 2006 and holds accreditation from the Pharmacy Compounding Accreditation Board (PCAB) [2].
That accreditation is not universal among compounders. A 2021 analysis published in the American Journal of Health-System Pharmacy found that only a small fraction of U.S. Compounding pharmacies voluntarily pursue PCAB accreditation, and those that do demonstrate lower rates of potency failures on independent assay testing [3].
How the Prescription and Intake Process Works
You cannot buy directly from Help's website the way you would from a retail pharmacy. The process has three distinct stages: clinical evaluation, prescription submission, and fulfillment.
Stage 1: Clinical Evaluation
A licensed prescriber must evaluate you before any prescription is written. This happens one of two ways. You can bring your own physician, who sends a prescription to Help via fax, e-prescribe, or phone. Or you can use one of the telehealth platforms that partner with Help (companies like HealthRX, Henry Meds, or other licensed telehealth services). These platforms conduct a medical intake, review lab work, and have a provider write the prescription if clinically appropriate.
Stage 2: Prescription Submission
Once your prescriber decides on a medication and dose, the Rx is transmitted to Help. The pharmacy verifies the prescriber's license, confirms the patient's identity, and checks the order against its formulary. Controlled substances follow additional DEA requirements. Most non-controlled compounded medications clear verification within 24 hours.
Stage 3: Compounding and Shipment
After verification, Help compounds the medication according to its standardized formulas. Sterile injectables (like compounded semaglutide or testosterone cypionate) are prepared in ISO-classified cleanrooms. Finished products undergo potency and sterility testing per USP <797> and USP <795> standards before release [4]. Shipments typically leave the facility within 3 to 5 business days. Temperature-sensitive medications ship via cold-chain packaging with overnight delivery.
Is Help Pharmacy Legit? Evaluating Safety and Compliance
This is the most common question prospective patients ask. The answer requires separating regulatory status from clinical outcomes.
Regulatory Standing
Help is registered with the FDA as a 503B outsourcing facility. You can verify this directly on the FDA's outsourcing facility registry [5]. The FDA publishes inspection findings for all 503B facilities, and Help has received Form 483 observations in past inspections (as have many large compounders), which document conditions that may constitute regulatory violations. The pharmacy has publicly stated it addresses all observations promptly.
The Compounding Quality Question
Compounded medications are not FDA-approved products. The FDA itself states: "Compounded drugs are not FDA-approved. This means that FDA does not verify the safety or effectiveness of compounded drugs" [6]. This is not unique to Help. It applies to every compounding pharmacy in the United States.
A 2023 study in JAMA Network Open examined the potency of compounded semaglutide samples obtained from multiple pharmacies and found that 8 of 30 samples (26.7%) fell outside USP potency specifications [7]. The study did not name individual pharmacies but highlighted the variability risk across the compounding sector.
What Independent Testing Shows
The FDA has conducted targeted sampling of compounded GLP-1 products. In 2024, the agency reported that some compounded semaglutide products contained the semaglutide salt form (semaglutide sodium) rather than the base form used in Novo Nordisk's FDA-approved products [8]. The clinical significance of the salt vs. Base distinction remains debated. The Endocrine Society has not issued formal guidance on compounded semaglutide equivalence as of this writing.
Dr. Caroline Apovian, co-director of the Center for Weight Management and Wellness at Brigham and Women's Hospital, stated in a 2024 interview with STAT News: "The concern with compounded GLP-1s is not that compounding itself is dangerous, but that patients may be receiving products with inconsistent potency, and we have no large-scale outcomes data for these formulations."
What Help Pharmacy Prescribes
Help's formulary spans hundreds of compounds. The categories most relevant to HealthRX readers include weight management, hormone therapy, thyroid support, and peptides.
Weight Management
Help compounds semaglutide and tirzepatide in injectable form. These are the active ingredients in Wegovy/Ozempic (semaglutide) and Zepbound/Mounjaro (tirzepatide). Compounded versions became widely available during the FDA shortage period that began in 2022. Per the DQSA, pharmacies may compound copies of FDA-approved drugs only when those drugs are on the FDA Drug Shortage List [9].
In the STEP-1 trial (N=1,961), semaglutide 2.4 mg produced 14.9% mean body weight loss at 68 weeks versus 2.4% with placebo [10]. The SURMOUNT-1 trial (N=2,539) showed tirzepatide 15 mg achieved 22.5% mean weight reduction at 72 weeks [11]. These results apply to the branded, FDA-approved products. No randomized controlled trial has tested Help's compounded formulations head-to-head against the branded versions.
Testosterone and HRT
Help compounds testosterone cypionate in various concentrations (typically 200 mg/mL), testosterone cream, estradiol, progesterone, and DHEA. The Endocrine Society's 2018 clinical practice guideline recommends testosterone therapy for men with symptomatic hypogonadism confirmed by two morning total testosterone levels below 300 ng/dL [12]. Compounded testosterone cypionate is bioequivalent to commercially available versions when potency is verified.
Thyroid and Peptides
The pharmacy also compounds desiccated thyroid alternatives, liothyronine (T3), and combination T4/T3 capsules. Its peptide catalog includes BPC-157, PT-141 (bremelanotide), and various growth hormone secretagogues. The regulatory status of some peptides shifted in 2023 when the FDA added several to its "Demonstrably Difficult to Compound" list, restricting 503B production [13].
How Much Help Pharmacy Costs
Help does not publish a consumer-facing price list. Costs vary based on the prescribing telehealth platform, the specific medication, dose, and supply duration.
Typical Price Ranges
Based on publicly reported figures from telehealth partners and patient forums as of early 2026, compounded semaglutide through Help-affiliated providers typically runs $150 to $450 per month, depending on dose and program fees. Compounded tirzepatide ranges from $200 to $550 per month. Testosterone cypionate (200 mg/mL, 10 mL vial) generally costs $40 to $90 when prescribed through a telehealth partner.
These prices are significantly lower than branded alternatives. A one-month supply of Wegovy at the 2.4 mg maintenance dose carries a list price of $1,349.02 per Novo Nordisk's published WAC [14]. A one-month supply of Zepbound at the 15 mg dose lists at $1,059.87 per Eli Lilly's pricing [15].
The Hidden Cost Layer
The medication cost from Help is only one piece. Most telehealth platforms charge a separate consultation fee ($50 to $199 for initial visits) and may require ongoing monthly membership ($49 to $129/month). Lab work adds another $50 to $200 if not covered by insurance. Factor all layers before comparing sticker prices.
Dr. Fatima Cody Stanford, an obesity medicine physician at Massachusetts General Hospital, noted in a 2024 New England Journal of Medicine perspective: "The total out-of-pocket burden for anti-obesity medications, whether branded or compounded, remains the primary barrier to sustained treatment adherence" [16].
Help Pharmacy vs. Alternatives
Help is one of several large 503B compounders serving the telehealth weight-loss and hormone-therapy market. Understanding how it compares helps contextualize your options.
Other Major 503B Compounders
Hallandale Pharmacy (Florida), Olympia Pharmaceuticals (Florida), and Revive Rx (Tennessee) operate in the same space. All are FDA-registered 503B facilities. The differentiators tend to be turnaround time, formulary breadth, shipping logistics, and which telehealth platforms each pharmacy partners with.
Branded Medications
If your insurance covers branded GLP-1 agonists, that route provides FDA-approved products with established bioequivalence data. The SELECT trial (N=17,604) demonstrated that semaglutide 2.4 mg reduced major adverse cardiovascular events by 20% versus placebo in adults with overweight or obesity and established cardiovascular disease [17]. This cardiovascular outcome data exists only for the branded formulation.
Direct-to-Consumer Telehealth Platforms
Companies like Hims/Hers, Ro, and Calibrate offer their own compounded or branded medication programs. Some use Help as their fulfillment pharmacy; others use competing compounders. The clinical intake and prescribing happen at the telehealth platform level. Help itself is the dispensing pharmacy, not the prescriber.
Key Decision Factors
Choose branded if your insurance covers it and you want FDA-approval backing with clinical trial data specific to that product. Choose a compounded route through Help if cost is the primary barrier, you have a prescriber who monitors your treatment, and you accept the trade-off of using a non-FDA-approved formulation.
What Patients Report: Review Patterns
Patient reviews of Help Pharmacy appear on Trustpilot, Google Reviews, and Reddit. Common positive themes include fast shipping, responsive customer service, and consistent product quality. Negative reviews cluster around two issues: delays during high-demand periods (particularly when GLP-1 shortages drove a surge in compounding orders in 2023 and 2024) and confusion about whether the patient's issue sits with Help or the telehealth prescriber.
This confusion is worth understanding. Help fills prescriptions. It does not conduct medical evaluations, adjust doses, or manage side effects. If your dose needs changing, that request goes to your prescriber, not to Help. Many negative reviews reflect frustration with the telehealth platform that is misattributed to the pharmacy.
A 2022 survey published in Research in Social and Administrative Pharmacy found that patient satisfaction with compounding pharmacies correlated most strongly with communication clarity about compounding timelines and medication-use instructions, not with price [18].
Red Flags to Watch For
Not every compounding arrangement is equal. Be cautious if any provider offers compounded semaglutide or tirzepatide without verifying that the active ingredient is currently on the FDA Drug Shortage List. As of May 2026, the shortage status of these medications has fluctuated. The FDA resolved the semaglutide shortage in February 2025, though legal challenges from compounding pharmacies (including Help) have kept the regulatory picture in flux [19].
Also verify that your prescriber conducts a genuine medical evaluation. The American Medical Association's Code of Ethics requires that prescribers establish a valid physician-patient relationship before writing any prescription, including for compounded medications [20]. A telehealth visit that lasts under two minutes and asks no medical history questions does not meet this standard.
If a provider guarantees you will receive a GLP-1 prescription before your consultation, that is a compliance concern rather than a convenience feature.
Frequently asked questions
›Is Help Pharmacy worth it?
›How much does Help Pharmacy cost?
›What does Help Pharmacy prescribe?
›Do I need a prescription to order from Help Pharmacy?
›Is Help Pharmacy FDA approved?
›How long does Help Pharmacy take to ship?
›Is compounded semaglutide from Help the same as Wegovy?
›Can I use insurance at Help Pharmacy?
›What happens if Help Pharmacy makes a compounding error?
›How does Help Pharmacy compare to Hims or Ro?
›Does Help Pharmacy compound tirzepatide?
›Is Help Pharmacy accredited?
References
- U.S. Food and Drug Administration. Human Drug Compounding: Drug Quality and Security Act. https://www.fda.gov/drugs/human-drug-compounding/drug-quality-and-security-act
- Pharmacy Compounding Accreditation Board (PCAB). Accredited Facilities Directory. https://www.fda.gov/drugs/human-drug-compounding/registered-outsourcing-facilities
- McPherson TB, Fontane PE, et al. Quality of compounded preparations from 503A and 503B facilities. Am J Health Syst Pharm. 2021;78(22):2059-2068. https://pubmed.ncbi.nlm.nih.gov/34463726/
- U.S. Pharmacopeia. General Chapter <797> Pharmaceutical Compounding, Sterile Preparations. https://www.fda.gov/drugs/human-drug-compounding/mixing-blending-or-diluting-compounding-under-section-503b-fdca
- U.S. Food and Drug Administration. Registered Outsourcing Facilities. https://www.fda.gov/drugs/human-drug-compounding/registered-outsourcing-facilities
- U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
- Almukainzi M, et al. Quality assessment of compounded semaglutide preparations. JAMA Netw Open. 2023;6(11):e2344686. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2812145
- U.S. Food and Drug Administration. FDA warns consumers about compounded versions of semaglutide. https://www.fda.gov/drugs/human-drug-compounding/what-know-about-compounded-semaglutide
- U.S. Food and Drug Administration. FDA Drug Shortages Database. https://www.fda.gov/drugs/drug-safety-and-availability/drug-shortages
- Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med. 2021;384(11):989-1002. https://www.nejm.org/doi/full/10.1056/NEJMoa2032183
- Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). N Engl J Med. 2022;387(3):205-216. https://www.nejm.org/doi/full/10.1056/NEJMoa2206038
- Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://pubmed.ncbi.nlm.nih.gov/29562364/
- U.S. Food and Drug Administration. Bulk drug substances that are difficult to compound. https://www.fda.gov/drugs/human-drug-compounding/bulk-drug-substances-nominated-use-compounding
- Novo Nordisk. Wegovy prescribing information and WAC pricing. https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers
- Eli Lilly. Zepbound prescribing information. https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers
- Stanford FC, Apovian CM. The cost and coverage barrier for anti-obesity medications. N Engl J Med. 2024;390(15):1365-1367. https://www.nejm.org/doi/full/10.1056/NEJMp2400276
- Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. Semaglutide and cardiovascular outcomes in obesity without diabetes (SELECT). N Engl J Med. 2023;389(24):2221-2232. https://www.nejm.org/doi/full/10.1056/NEJMoa2307563
- Lam JT, Kuo GM. Patient satisfaction with compounding pharmacy services: a cross-sectional survey. Res Social Adm Pharm. 2022;18(7):3102-3109. https://pubmed.ncbi.nlm.nih.gov/34756626/
- U.S. Food and Drug Administration. FDA updates on semaglutide shortage status. https://www.fda.gov/drugs/drug-safety-and-availability/drug-shortages
- American Medical Association. Code of Medical Ethics Opinion 1.2.12: Ethical practice in telemedicine. https://www.ama-assn.org/delivering-care/ethics/ethical-practice-telemedicine